Risk of Pneumothorax With and Without Chest Tube Clamping in Patients With Pleural Pathology
- Conditions
- PneumothoraxChest TubePleural Diseases
- Registration Number
- NCT05243316
- Brief Summary
Through this randomized controlled clinical trial, we aim to identify whether there is a difference in the incidence of 24 hour pneumothorax after chest tube removal, in two blindly randomized groups of patients: The first group with chest tube clamping 6 hours prior to removal, and the second group there will be no chest tube clamping.
The data will be prospectively collected from patient records from the National Institute of Respiratory Diseases Ismael Cosío Villegas.
- Detailed Description
Patients with an indication of chest tube removal will be randomized to two possible arms: clamping (for 6 hours before removal) or not clamping (immediate removal).
Incidence of 24hour pneumothorax after chest tube removal will be recorded.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 93
- Patients aged 16 years and more.
- Patients hospitalized in the National Institute of Respiratory Diseases.
- Patients who had a chest tube placement during their stay at the hospital, by any cause.
- Patients who refuse to sign the informed consent and who refuse to participate in the study.
- Patients who die before randomization.
- Patients who gets chest tube removal before being randomized.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Incidence of pneumothorax after chest tube removal without chest tube clamping After 24 hours of procedure Cases of pneumothorax after chest tube removal despite clamping
Incidence of pneumothorax after chest tube removal with chest tube clamping After 24 hours of procedure Cases of pneumothorax after chest tube removal despite clamping
- Secondary Outcome Measures
Name Time Method Hospital days of stay Through study completion, an average of 1 month Hospital days of stay
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (1)
National Institute of Respiratory Diseases
🇲🇽Mexico City, Mexico
National Institute of Respiratory Diseases🇲🇽Mexico City, Mexico